Treatment of Residual Pockets in Periodontal Patients Using an Oscillating Chitosan Device

November 16, 2023 updated by: Georgia Tseleki, Aristotle University Of Thessaloniki

Treatment of Residual Pockets in Periodontal Patients Using an Oscillating Chitosan Device - A Randomized Parallel Arm Clinical Trial

The aim of the current study was to investigate the effect of a chitosan brush on the treatment of residual pockets in patients already treated for periodontal disease. Thirty-six patients with chronic periodontitis (Stage ΙΙΙ, ΙV) that had already completed causative therapy and exhibited at least two residual periodontal pockets ≥ 5mm that bled on probing, were randomly assigned to two groups. In the test group debridement of residual pockets was performed with ultrasonic scaler and the chitosan brush, whereas in the control group only ultrasonic scalers were used.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Thessaloniki, Greece
        • Department of Periodontology, School of Dentistry, Aristotle University of Thessaloniki

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Subjects aged 18 or over
  • Subjects diagnosed with chronic periodontitis, Stage III or IV, and had received full mouth scaling and root planning at least three months prior to baseline examination
  • Subjects with at least two residual periodontal pockets of at least 5mm depth that bled on probing
  • Full mouth plaques scores ≤20%

Exclusion Criteria:

  • Subjects that had received antibiotic therapy 6 months prior to initial examination
  • Subjects with compromised systemic conditions
  • Patients undergoing chemotherapy or radiotherapy
  • Pregnant or lactating women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: chitosan group
debridement of residual periodontal pockets with ultrasonic scaler and the chitosan brush
debridement of periodontal pockets with ultrasonic scaler first and after with chitosan brush for 2 minutes
Other Names:
  • Labrida BioClean
debridement of periodontal pockets only with ultrasonic scaler
Active Comparator: control group
debridement of residual periodontal pockets with ultrasonic scaler only
debridement of periodontal pockets only with ultrasonic scaler

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Probing Pocket Depth
Time Frame: baseline, 6 weeks, 3 months, 6 months
the distance from the mucosa margin to the bottom of the periodontal pocket
baseline, 6 weeks, 3 months, 6 months
MMP-8
Time Frame: baseline, 6 weeks, 3 months, 6 months
levels of matrix metalloproteinase -8 in gingival crevicular fluid
baseline, 6 weeks, 3 months, 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bleeding on Probing
Time Frame: baseline, 6 weeks, 3 months, 6 months
presence or absence of bleeding after probe insertion in the periodontal pocket
baseline, 6 weeks, 3 months, 6 months
Clinical Attachment Level
Time Frame: baseline, 6 weeks, 3 months, 6 months
the distance from cementoenamel junction to the bottom of periodontal pocket
baseline, 6 weeks, 3 months, 6 months
Gingival Recession
Time Frame: baseline, 6 weeks, 3 months, 6 months
the distance from cementoenamel junction to the mucosa margin
baseline, 6 weeks, 3 months, 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Lazaros Tsalikis, Department of Periodontology, School of Dentistry, Aristotle University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 8, 2021

Primary Completion (Actual)

November 29, 2022

Study Completion (Actual)

November 29, 2022

Study Registration Dates

First Submitted

November 7, 2023

First Submitted That Met QC Criteria

November 7, 2023

First Posted (Actual)

November 13, 2023

Study Record Updates

Last Update Posted (Estimated)

November 17, 2023

Last Update Submitted That Met QC Criteria

November 16, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Periodontitis

Clinical Trials on chitosan brush

3
Subscribe